145 related articles for article (PubMed ID: 7534896)
21. The relationship between vascularity and cell proliferation in human normal and pathological lesions of the oral cheek epithelium.
Tipoe GL; Jin Y; White FH
Eur J Cancer B Oral Oncol; 1996 Jan; 32B(1):24-31. PubMed ID: 8729615
[TBL] [Abstract][Full Text] [Related]
22. Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions.
Heyden A; Huitfeldt HS; Koppang HS; Thrane PS; Bryne M; Brandtzaeg P
J Oral Pathol Med; 1992 Jan; 21(1):7-11. PubMed ID: 1375644
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Ca 1 monoclonal antibody in distinguishing oral squamous cell carcinoma from non-malignant or premalignant oral lesions.
Masouredis CM; Green TL; Greenspan JS
J Oral Pathol; 1987 Jul; 16(6):307-9. PubMed ID: 3119804
[TBL] [Abstract][Full Text] [Related]
24. Staining patterns of human pre-malignant oral epithelium and squamous cell carcinomas by monoclonal anti-keratin antibodies.
Reibel J; Clausen H; Dabelsteen E
Acta Pathol Microbiol Immunol Scand A; 1985 Nov; 93(6):323-30. PubMed ID: 2418629
[TBL] [Abstract][Full Text] [Related]
25. Assessment of proliferating cell nuclear antigen expression in precursor stages of gastric carcinoma using the PC10 antibody to PCNA.
Filipe MI; Mendes R; Lane DP; Morris RW
Histopathology; 1993 Apr; 22(4):349-54. PubMed ID: 8099897
[TBL] [Abstract][Full Text] [Related]
26. Expression of proliferating cell nuclear antigen (PCNA) in oral submucous fibrosis, oral epithelial hyperkeratosis and oral epithelial dysplasia in Taiwan.
Chiang CP; Lang MJ; Liu BY; Wang JT; Leu JS; Hahn LJ; Kuo MY
Oral Oncol; 2000 Jul; 36(4):353-9. PubMed ID: 10899674
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of heme oxygenase-1 in oral epithelial dysplasias.
Lee J; Lee SK; Lee BU; Lee HJ; Cho NP; Yoon JH; Choi HR; Lee SK; Kim EC
Int J Oral Maxillofac Surg; 2008 Mar; 37(3):287-92. PubMed ID: 18272347
[TBL] [Abstract][Full Text] [Related]
28. Potential role of minichromosome maintenance protein 2 as a screening biomarker in esophageal cancer high-risk population in China.
Huang B; Hu B; Su M; Tian D; Guo Y; Lian S; Liu Z; Wu X; Li Q; Zheng R; Gao Y
Hum Pathol; 2011 Jun; 42(6):808-16. PubMed ID: 21237484
[TBL] [Abstract][Full Text] [Related]
29. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.
Zidar N; Gale N; Cör A; Kambic V
J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312
[TBL] [Abstract][Full Text] [Related]
30. Distribution of proliferating-cell nuclear antigen and epidermal growth factor receptor in intraepithelial squamous cell lesions of human bronchus.
Yoneda K
Mod Pathol; 1994 May; 7(4):480-6. PubMed ID: 7915034
[TBL] [Abstract][Full Text] [Related]
31. Suprabasal 40 kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium.
Lindberg K; Rheinwald JG
Am J Pathol; 1989 Jan; 134(1):89-98. PubMed ID: 2464285
[TBL] [Abstract][Full Text] [Related]
32. Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma.
Lu EM; Ratnayake J; Rich AM
BMC Oral Health; 2019 Oct; 19(1):233. PubMed ID: 31672124
[TBL] [Abstract][Full Text] [Related]
33. Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland.
Cruz I; Napier SS; van der Waal I; Snijders PJ; Walboomers JM; Lamey PJ; Cowan CG; Gregg TA; Maxwell P; Meijer CJ
J Clin Pathol; 2002 Feb; 55(2):98-104. PubMed ID: 11865002
[TBL] [Abstract][Full Text] [Related]
34. Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinoma - an aid to conventional histological grading?
Zain RB; Sakamoto F; Shrestha P; Mori M
Malays J Pathol; 1995 Jun; 17(1):23-30. PubMed ID: 8907001
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis.
Nitta T; Sugihara K; Tsuyama S; Murata F
Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953
[TBL] [Abstract][Full Text] [Related]
36. Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
Thomas H; Nasim MM; Sarraf CE; Alison MR; Love S; Lambert HE; Price P
Br J Cancer; 1995 Feb; 71(2):357-62. PubMed ID: 7841053
[TBL] [Abstract][Full Text] [Related]
37. Expression of p63 protein and mRNA in oral epithelial dysplasia.
Chen YK; Hsue SS; Lin LM
J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
[TBL] [Abstract][Full Text] [Related]
38. [An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords].
Urano M; Iwata S; Takasu A; Mori S; Sakurai K; Katoh H; Yamamoto S; Kasahara M; Kuroda M; Hakuno T
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):395-401. PubMed ID: 8934774
[TBL] [Abstract][Full Text] [Related]
39. Expression of mucin type carbohydrates may supplement histologic diagnosis in oral premalignant lesions.
Bryne M; Reibel J; Mandel U; Dabelsteen E
J Oral Pathol Med; 1991 Mar; 20(3):120-5. PubMed ID: 1709970
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of a fluorescence visualization system for the detection of oral precancerous and early cancerous lesions.
Ohnishi Y; Fujii T; Ugaki Y; Yasui H; Watanabe M; Dateoka S; Kakudo K
Oncol Rep; 2016 Jul; 36(1):514-20. PubMed ID: 27121913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
